In-Depth Phenotyping of PIGW-Related Disease and Its Role in 17q12 Genomic Disorder
Biomolecules · 2024
DOI: 10.3390/biom14121626 ↗Kurz gefasst
Fallbericht in der Zeitschrift Biomolecules, 2024. Verfasst von Agnese Feresin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgery and Health Sciences, University of Trieste, 34127 Trieste, Italy. Hauptthemen laut MEDLINE: Phenotype. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Next Generation EU, European Union.
Abstract (Originalsprache)
Glycosylphosphatidylinositol (GPI) biosynthesis defect 11 (GPIBD11), part of the heterogeneous group of congenital disorders of glycosylation, is caused by biallelic pathogenic variants in PIGW. This rare disorder has previously been described in only 12 patients. We report four novel patients: two sib fetuses with congenital anomalies affecting several organs, including the heart; a living girl with tetralogy of Fallot, global developmental delay, behavioral abnormalities, and atypic electroencephalography (EEG) without epilepsy; a girl with early-onset, treatment-resistant seizures, developmental regression, and recurrent infections, that ultimately passed away prematurely due to pneumonia. We also illustrate evolving facial appearance and biochemical abnormalities. We identify two novel genotypes and the first frameshift variant, supporting a loss-of-function pathogenic mechanism. By merging our cohort with patients documented in the literature, we deeply analyzed the clinical and genetic features of 16 patients with PIGW-related disorder, revealing a severe multisystemic condition deserving complex management and with uncertain long-term prognosis. We consider the role of PIGW within the critical 17q12 region, which is already associated with genomic disorders caused by deletion or duplication and characterized by variable expressivity. Finally, we discuss PIGW dosage effects and a second hit hypothesis in human development and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Surgery and Health Sciences, University of Trieste, 34127 Trieste, Italy.
- SoFFoet, Société Française de Fœtopathologie, 75015 Paris, France.
- UF de Foetopathologie, CHU d'Orléans, 45100 Orleans, France.
- Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, 4293 Dianalund, Denmark.
- Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", 34137 Trieste, Italy.
- Inserm-UB UMR 1231 GAD "Génétique des Anomalies du Développement", Fédération Hospitalo-Universitaire-TRANSLAD, 21000 Dijon, France.
ORCID-Profile: Agnese Feresin, Mathilde Lefebvre, Emilie Sjøstrøm, Caterina Zanus, Elisa Paccagnella, Erica Valencic, Anna Morgan, Alberto Tommasini, Allan Bayat, Giorgia Girotto, Luciana Musante
Förderung
- Next Generation EU
- European Union
Zitieren
APA
Feresin, A., Lefebvre, M., Sjøstrøm, E., Zanus, C., Paccagnella, E., Bruno, I., Valencic, E., Morgan, A., Tommasini, A., Thauvin, C., Bayat, A., Girotto, G., & Musante, L. (2024). In-Depth Phenotyping of PIGW-Related Disease and Its Role in 17q12 Genomic Disorder. Biomolecules. https://doi.org/10.3390/biom14121626
Vancouver
Feresin A, Lefebvre M, Sjøstrøm E, Zanus C, Paccagnella E, Bruno I, et al. In-Depth Phenotyping of PIGW-Related Disease and Its Role in 17q12 Genomic Disorder. Biomolecules. 2024. doi:10.3390/biom14121626
BibTeX
@article{Feresin2024,
author = {Feresin, Agnese and Lefebvre, Mathilde and Sjøstrøm, Emilie and Zanus, Caterina and Paccagnella, Elisa and Bruno, Irene and Valencic, Erica and Morgan, Anna and Tommasini, Alberto and Thauvin, Christel and Bayat, Allan and Girotto, Giorgia and Musante, Luciana},
title = {In-Depth Phenotyping of PIGW-Related Disease and Its Role in 17q12 Genomic Disorder},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14121626}
}
EUVIMED